Latest News and Press Releases

BUFFALO, N.Y., April 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...

BUFFALO, N.Y., April 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...

BUFFALO, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...

VLN® cigarettes from 22nd Century Group (Nasdaq: XXII) contain 95% less nicotine than conventional cigarettes; now available in select Circle K convenience stores CHICAGO, April 13, 2022 (GLOBE...

Further Enhances 22nd Century Group’s Deep Expertise in Plant-Based Biotechnology BUFFALO, N.Y., April 11, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural...

BUFFALO, N.Y., March 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), today announced that it has received notification from the Office of the Illinois Attorney General’s...

BUFFALO, N.Y., March 09, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...

미국 뉴욕주 버팔로, March 02, 2022 (GLOBE NEWSWIRE) -- 농업 바이오테크 기업으로 담배위해감소, 니코틴 저감 담배, 첨단 식물과학을 통한 보건 및 건강 증진 분야에 주력하는 22nd Century Group, Inc. (Nasdaq: XXII)은 자사의 니코틴 저감 담배 VLN®에 대한 첫 해외 판매 시장으로 16억 달러...

Secured FDA MRTP Authorization for VLN® King and VLN® Menthol King Reduced Nicotine Content CigarettesAdvancing to U.S. Pilot Market Launch in ChicagoAnnounced Circle K as First VLN® Retail Trade...

BUFFALO, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...